Articles On IDT Australia (ASX:IDT)

07 Jan 2020 - The Cann Group (ASX:CAN) and IDT Australia (ASX:IDT) have jointly announced that GMP extraction activities are underway for the first batches of medicinal cannabis re…

The Cann Group Ltd (ASX: CAN) share price has returned from its trading halt and rocketed higher. In morning trade the cannabis company’s shares are up 25% to $1.26. Why is the Cann Group share price rocketing higher on Tuesday? Investors...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Few people are at their desks in the week between Christmas and new year, which means it’s a prime dumping period for companies wanting to hide bad news. But there’s always someone who draws the short straw in a newsroom and this year it wa...

The Cann Group Ltd (ASX: CAN) share price was the best performer on the All Ordinaries index on Monday before being placed in a trading halt. The cannabis company’s shares were up as much as 28% to $1.03 at one stage today. And were 25.5%...

This year was a difficult one for ASX cannabis shares as well as cannabis stocks globally with share prices worldwide retreating from previous highs. In Australia the medical marijuana industry remains in its infancy. Nonetheless, the init...

Invion (ASX:IVX) may have a new Chinese partner to help get its cosmetics business off the ground. The company told shareholders this morning it signed an MoU with Pavay Biotech, an established provider of dermatology treatment products in...

Cannabis industry is booming at a rapid pace, with several governments creating opportunities for investors by legalising recreational and medicinal cannabis. With increasing legalisation of cannabis, number of investors and entrepreneurs j...

The AusCann Group Holdings Ltd (ASX: AC8) share price certainly was out of form on Thursday. The medicinal cannabis company’s shares were the worst performers on the All Ordinaries with a decline of 13% to 23.5 cents. Why did the AusCann s...

In afternoon trade the S&P/ASX 200 index is on course to finish the day lower. At the time of writing the benchmark index is down 0.1% to 6,843.6 points. Four shares that have not let that hold them back today are listed below. Here’s...

The new COO has more than 30 years’ experience in the pharmaceutical industry in Australia and the UK including roles at PCI Clinical Services, LEO Pharma, IDT Australia, GlaxoSmithKline and Pfizer.

Cann Global (ASX:CGB) has become the second small cap to enter the African cannabis market. It is a market that is estimated to reach $7.1 billion by 2023 although is only legal in three countries including South Africa, Zimbabwe and Lesoth...

Cann Group (ASX: CAN) has confirmed the first commercial medicinal cannabis product to be made at Cann’s Australian-based cultivation operations has been packed by IDT Australia (ASX: IDT) in preparation for commercial release in the new ye...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

In morning trade the Cann Group Ltd (ASX: CAN) share price is rocketing higher. At the time of writing the cannabis company’s shares are up 20% to 51 cents. Why is the Cann Group share price rocketing higher? Investors have been buying Can...

In the global medical cannabis market scenario, Australian cannabis market is the fastest one growing in leaps and bounds. The use of cannabis as a pharmaceutical product for the therapy in severe medical conditions such as Alzheimer’s dise...

Lately, cannabis stocks in the US have come under pressure, following the rising death toll from vaping that reached 42 so far in 2019, according to media reports. Meanwhile, in Canada, Canopy Growth unveiled that returned cannabis oil prod...

Cannabis Industry The Australian cannabis industry is the newest and the most dynamic sector after the legalization of cannabis for medicinal as well as recreational purposes. The cannabis industry refers to the activities and all the profe...

The Cann Group Ltd (ASX: CAN) share price is having a rare positive day of trade. In morning trade the cannabis company’s shares are up 4% to $1.05. This has reduced its one-month decline to approximately 30%. Why is the Cann Group share p...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

Cannabis industry in Australia is growing at a fast pace, and government authorities across the country are creating a lot of prospects for investors by legalising medicinal cannabis. Moreover, it is being assumed that the Australia cannabi...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

Shares in biotech Orthocell (ASX:OCC) are on the move again today after the company reported further positive results for its CelGro technology. Patients who completed the company’s CelGro tendon regeneration trial reported they had regaine...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

Cannabis: An Overview The cannabis industry is booming at a rapid pace with governments across the globe creating the opportunities for investors by legalising recreational and medicinal cannabis. Legalisation of cannabis by government auth...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

The increasing use of medical cannabis products has prompted many countries to soften the regulations regarding the manufacturing and consumption of cannabis products. Last year, Canada became the second and the largest country in the world...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

The progress of the Australian medical cannabis industry since its legalisation indicates that the country is following the footsteps of Canada, attracting established international players. The market experts believe that the Australian ca...

The Cann Group Ltd  (ASX: CAN) share price could trade heavily this morning after the medicinal cannabis company announced its latest quarterly activities to the market. What did the Cann Group announce this morning? In its latest quarterl...

Cannabis can be understood as a nature-oriented medicine from the cannabis plants, used for medical as well as recreational purpose across the globe. Australia enjoys a long history in relation to the manufacturing of pharmaceutical grade m...

Australia’s pharmaceutical industry is innovative and immensely supports economic prosperity of the nation. The constituent companies not only provide treatments to save lives but also contribute to Australian economy by undertaking busines...

One of Australia’s leading cannabis developers, Cann Group (ASX: CAN) has been approved to manufacture cannabis products at its existing northern and southern medicinal cannabis facilities in Melbourne. The licences relate to the manufactur...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

Wth the legalisation of medical cannabis in many countries like Canada, the global medical cannabis industry has boomed quite a bit in recent times. Let’s take a quick look at 20 cannabis companies trading on ASX. Cann Group Limited (ASX:...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

Medical cannabis uses the marijuana plant or chemicals extracted from the plant for the treatment of diseases and symptoms, the plant (cannabis) possess over a hundred different chemicals called cannabinoids. There are a few forms of cannab...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...